Skip to main content
. 2016 Feb 11;9:7–17. doi: 10.2147/IJGM.S93698

Figure 2.

Figure 2

Reduction of IBS symptoms with Bifidobacterium infantis capsule administered once daily vs placebo.

Notes: Females with IBS-D recruited from primary care centers were randomized to receive B. infantis 35624 1×108 (n=49) or placebo (n=56) once daily for 4 weeks. Data are least-squares mean changes from baseline at week 4. *P<0.03 vs placebo. Data from Whorwell et al.54

Abbreviations: IBS, irritable bowel syndrome; IBS-D, diarrhea-predominant IBS.